🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Chong-xian Pan

Harvard University

ORCID: 0000-0002-8588-3994

Also affiliated with VA Boston Healthcare System, Mass General Brigham

Computer ScienceMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.332Author DataRank

Indexed papers

4in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 4 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349
Top 62%
0.222DataRank
Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

Papers

Driven by 11 papers — median percentile 28. Top paper: “RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics”.

RAF1 amplification drives a subset of bladder tumors and confers sensitivity to MAPK-directed therapeutics

Journal of Clinical Investigation(2021)10.1172/jci147849
N/A
0.533DataRank · unranked
34 citations

Amruta S. Samant, Amin H. Nassar, Jonathan So, Elizabeth P. Garcia, Catherine R. Curran +13 more

A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis

Cancer Research(2024)10.1158/0008-5472.can-23-1349
Top 62%
0.222DataRank
Top 62%3 citations

Xing Yi Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +49 more

ARID1A-mutant and deficient bladder cancer is sensitive to EZH2 pharmacologic inhibition

10.1101/2021.01.12.426383
N/A
0.165DataRank · unranked
2 citations

Hasibur Rehman, Darshan S. Chandrashekar, Balabhadrapatruni V. S. K. Chakravarthi, Saroj Nepal, Marie-Lisa Eich +10 more

PDXNet Portal: Patient-Derived Xenograft model, data, workflow, and tool discovery

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.15.464537
Top 72%
0.110DataRank
Top 72%1 citations

Michael W. Lloyd, Jeffrey Grover, Sara Seepo, Sai Lakshmi Subramanian, Manisha Ray +34 more

A pan-cancer PDX histology image repository with genomic and pathological annotations for deep learning analysis

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.10.26.512745
Top 100%
0DataRank
Top 100%0 citations

X. Woo, Soner Koc, Todd Sheridan, Steven B. Neuhauser, Shidan Wang +45 more

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

Scientific Reports(2023)10.1038/s41598-023-36774-1
N/A
0DataRank · unranked
11 citations

Maria Malvina Tsamouri, Salma Siddiqui, Christopher A. Lucchesi, Demitria M. Vasilatis, Benjamin A. Mooso +8 more

Data from Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer

(2023)10.1158/1078-0432.c.6532902
N/A
0DataRank · unranked
0 citations

Ai‐Hong Ma, Hongyong Zhang, Tzu‐yin Lin, Xiangdong Xue, Hizra Farrukh +10 more

Phototherapy with Cancer-Specific Nanoporphyrin Potentiates Immunotherapy in Bladder Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1362
N/A
0DataRank · unranked
30 citations

Ai‐Hong Ma, Hongyong Zhang, Tzu‐yin Lin, Xiangdong Xue, Hizra Farrukh +10 more

Novel Nanococktail of a Dual PI3K/mTOR Inhibitor and Cabazitaxel for Castration‐Resistant Prostate Cancer

Advanced Therapeutics(2020)10.1002/adtp.202000075
N/A
0DataRank · unranked
12 citations

Xiangdong Xue, Xiaocen Li, Bei Jia, Chong-xian Pan, Yuanpei Li +2 more

ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors

JCI Insight(2022)10.1172/jci.insight.155899
N/A
0DataRank · unranked
65 citations

Darshan S. Chandrashekar, Chakravarthi Balabhadrapatruni, Saroj Nepal, Sai Akshaya Hodigere Balasubramanya, Abigail Shelton +15 more

Self‐Assembled Nanoparticle‐Mediated Chemophototherapy Reverses the Drug Resistance of Bladder Cancers through Dual AKT/ERK Inhibition

Advanced Therapeutics(2020)10.1002/adtp.202000032
N/A
0DataRank · unranked
15 citations

Xiangdong Xue, Ai‐Hong Ma, Yuan Ruan, Hongyong Zhang, Cheng Fan +4 more